Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lucy A Godley

Showing results (1-10 of 223) with videos related to

Pageof 23
Sort By:
Blood|June 13, 2024
What WAS disease risk then versus now?Lucy A Godley
The New England Journal of Medicine|March 16, 2012
Profiles in leukemiaLucy A Godley
Frontiers in Oncology|February 16, 2023
Prioritization of patients for germline testing based on tumor profiling of hematopoietic malignanciesLucy A Godley
Leukemia & Lymphoma|August 18, 2021
Anticipation in hematopoietic malignancies: biology, bias, or both?Lucy A Godley
Current Opinion in Hematology|January 4, 2021
Germline mutations in MDS/AML predisposition disordersLucy A Godley
Leukemia & Lymphoma|October 6, 2007
HMGA2 levels in CML: reflective of miRNA gene regulation in a hematopoietic tumor?Lucy A Godley
Leukemia & Lymphoma|May 30, 2009
Deletion of the der(9q) in chronic myeloid leukemia: the controversy continuesLucy A Godley
Blood|March 18, 2017
<i>DNAJC21</i>: the new kid on the SDS blockLucy A Godley
Blood|June 22, 2019
FouNdER mutations confer risk for leukemiasLucy A Godley
Blood Advances|September 12, 2019
Inherited predisposition to myeloid malignanciesLucy A Godley
Pageof 23

Showing results (1-10 of 223) with videos related to

Sort By:
Pageof 23
Blood|June 13, 2024
What WAS disease risk then versus now?Lucy A Godley
The New England Journal of Medicine|March 16, 2012
Profiles in leukemiaLucy A Godley
Frontiers in Oncology|February 16, 2023
Prioritization of patients for germline testing based on tumor profiling of hematopoietic malignanciesLucy A Godley
Leukemia & Lymphoma|August 18, 2021
Anticipation in hematopoietic malignancies: biology, bias, or both?Lucy A Godley
Current Opinion in Hematology|January 4, 2021
Germline mutations in MDS/AML predisposition disordersLucy A Godley
Leukemia & Lymphoma|October 6, 2007
HMGA2 levels in CML: reflective of miRNA gene regulation in a hematopoietic tumor?Lucy A Godley
Leukemia & Lymphoma|May 30, 2009
Deletion of the der(9q) in chronic myeloid leukemia: the controversy continuesLucy A Godley
Blood|March 18, 2017
<i>DNAJC21</i>: the new kid on the SDS blockLucy A Godley
Blood|June 22, 2019
FouNdER mutations confer risk for leukemiasLucy A Godley
Blood Advances|September 12, 2019
Inherited predisposition to myeloid malignanciesLucy A Godley
Pageof 23